LARP1 post-transcriptionally regulates mTOR and contributes to cancer progressionManuela Mura, Sarah P. Blagden, T.G. Hopkins et al.|Oncogene|2014Cited by 152
A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritizationClare Pacini, Mathew J. Garnett, Edward Curry et al.|Cancer Cell|2024Cited by 90
Dose-Finding Quantitative <sup>18</sup>F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic MalignanciesHatice Güngör, Hani Gabra, Azeem Saleem et al.|Journal of Nuclear Medicine|2015Cited by 27
Mutation and Protein Expression Biomarkers Correlate with Response to AKT Inhibition in a Phase I Trial of the Oral Pan AKT Inhibitor GSK2141795 (GSK795) in Patients (pts) with Platinum Resistant Ovarian CancerH. Gunqor, Hani Gabra, Edward Curry et al.|European Journal of Cancer|2011Cited by 1